MedTrace Logo

Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy

NCT01284764 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2011-10-05

No results posted yet for this study

Summary

A low volume of water intake and mosapride will effectively reduce food residue in remnant stomach for patients who had undergone subtotal gastrectomy due to gastric cancer.

Conditions

  • Foreign Body Left During Endoscopic Examination

Interventions

DRUG

Mosapride

Mosapride 10mg, one dosage, once evening of the day before the endoscopy

Sponsors & Collaborators

  • Inje University

    lead OTHER

Principal Investigators

  • Eun Hee Seo, M.D. · Haeundae Paik Hospital

  • Tae Oh Kim, Ph.D. · Haeundae Paik Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-07-31
Completion
2011-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01284764 on ClinicalTrials.gov